Héma-Québec quarantines blood products as a precautionary measure

Montréal, November 29, 2012 – Héma-Québec would like to inform the public that the blood products currently available for transfusion are perfectly safe.

As a precautionary measure, Héma-Québec has asked Québec hospitals to temporarily quarantine certain blood products due to microscopic punctures found on a few blood bags.

Tests are currently being performed on the quarantined blood products. Based on these results, safe products will be put back into circulation.

Héma-Québec has taken the necessary measures to meet the needs of patients waiting for a transfusion. There is therefore no current shortage of blood.

We would also like to stress that patients who recently received transfusions all received products that were deemed safe, and there is no risk to their health.

Should there be any new developments, further details will be provided.

 
About Héma-Québec
Héma-Québec's mission is to efficiently provide adequate quantities of safe, optimal blood components, substitutes, human tissues and cord blood to meet the needs of all Quebecers; to provide and develop expertise along with specialized and innovative services and products in the fields of transfusion medicine and human tissue transplantation.
 
Héma-Québec encompasses 1,300 employees, some 3,000 blood drives and more than 160,000 blood donors every year, 16,000 volunteers and more than 500,000 blood products delivered annually to Québec hospitals to meet the needs of patients.
 
Give blood. Give life.
 
- 30 -
 
Information:    
Héma-Québec                
Media Line | 514-832-0871